Skip to main content
SpringerLink
Log in

Nilvadipine: an alternative dihydropyridine for treating hypertension

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brogden RN, McTavish D. Nilvadipine: a review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension an potential in cerebrovascular disease and angina. Drug Aging 1995; 6: 150–71

    Article  CAS  Google Scholar 

  2. Kelly JG, O’Malley K. Clinical pharmacokinetics of calcium antagonists: an update. Clin Pharmacokinet 1992; 22: 416–33

    Article  PubMed  CAS  Google Scholar 

  3. Wang W, Zhao F, Yu X, et al. Effect of treatment with nimodipine in patients with mild and moderate essential hypertension. J Hum Hyper 1990; 4: 149–50

    CAS  Google Scholar 

  4. Frampton JE, Faulds D. Nicardipine: a review of its pharmacology and therapeutic efficacy in older patients. Drug Aging 1993; 3: 165–87

    Article  CAS  Google Scholar 

  5. Wadworth AN, McTavish D. Nimodipine: a review of its pharmacological properties, and therapeutic efficacy in cerebral disorders. Drug Aging 1992; 262–86

    Google Scholar 

  6. British National Formulary No. 28. London: The Pharmaceutical Press, 1994; 89–93

  7. 1995 Physicians GenRx. St. Louis, Missouri: Mosby-Year Book, Inc., 1995

  8. Ogihara T, Mikami H, Otsuka A, et al. Effect of nilvadipine on quality of life in the treatment of hypertension. Curr Ther Res 1992; 51: 154–62

    Google Scholar 

  9. Ohkura T, Itoh A, Miyachi J, et al. Pharmacokinetics of nilvadipine, a calcium channel blocking agent, in patients with impaired renal functions. Rinsho Iyaku 1986; 2: 1497–506

    Google Scholar 

  10. Faust G. One-year study of nilvadipine administered once a day. Efficacy and long-term tolerability in hypertensives [in German]. Fortschr Med 1993; 111: 188–92

    PubMed  CAS  Google Scholar 

  11. Fritschka E. Comparisons of once-daily nilvadipine with enalapril and diuretic in patients with essential hypertension. J Cardiovasc Pharmacol 1992; 20 Suppl. 6: S62–8

    PubMed  Google Scholar 

  12. Ikeda M, Kaneko Y, Kuramochi M, et al. Clinical utility of nilvadipine (FK 235) in the treatment of essential hypertension, and on hypotensive effect and degree of reduced pressure stemming from each [in Japanese]. Shinryo to Shinyaku 1992; 29: 2435–45

    Google Scholar 

  13. Keck M. Comparison of the efficacy of nilvadipine and nitrendipine on circadian blood pressure. J Cardiovasc Pharmacol 1992; 20 Suppl.6: S43–9

    PubMed  Google Scholar 

  14. Yamamoto T. Comparison between nilvadipine and captopril, each given on long term single dosage basis to aged and middle-aged patients with essential hypertension, and on hypotensive effect and degree of reduced pressure stemming from each [in Japanese]. Shinryo to Shinyaku 1992; 29: 2435–45

    Google Scholar 

  15. Lederle RM, Lederle E. Combination of nilvadipine with a beta-blocker in essential hypertension [in German]. Munch Med Wochenshcr 1992; 134: 711–5

    Google Scholar 

  16. Ono K. Antihypertensive effect of a new calcium antagonist, nilvadipine in combination with metoprolol in essential hypertension [in Japanese]. Kiso-to-Rinsho 1986; 20: 5997–6005

    Google Scholar 

  17. Ohtomo E, Tohgie H, Kogure K, et al. Clinical evaluation of nilvadipine (FK235) on chronic cerebrovascular disorder — late phase II multicenter dose-finding double blind group comparative study [in Japanese]. Rinsho Iyaku 1991; 7: 103–27

    Google Scholar 

  18. Ohtomo E, Tohgie H, Kogure K, et al. Clinical efficacy of nilvadipine (FK235) on cerebral infarction: multicenter double blind group comparative study of nicardipine hydrochloride [in Japanese]. Rinsho Iyaku 1991; 7: 389–412

    Google Scholar 

  19. Kato K, Takahashi N, Iimura O, et al. Clinical effect of nilvadipine on angina pectoris: a multi-center double-blind comparative study between 8mg b.i.d. and 4 mg t.i.d. [in Japanese]. Rinsho Iyaku 1994; 10: 199–215

    Google Scholar 

  20. Kato T, Takahashi N, Murayama M, et al. Comparison of the antianginal effects of nilvadipine (FK 235) and diltiazem in patients with exertional angina [in Japanese]. Rinsho Iyaku 1987; 3: 105–32

    Google Scholar 

  21. Nakamura Y, Miyashita H, Iimura O, et al. A group comparative double-blind trial of nilvadipine with nifedipine in the treatment of angina pectoris in a multicenter cooperation [in Japanese]. Rinsho Iyaku 1986; 2: 1657–76

    Google Scholar 

  22. Kishida H, Toyama S, Yanaga T, et al. Effect of a new calcium antagonist, nilvadipine, on variant angina pectoris evaluated by 24-hour holter electrocardiography. Jpn Heart J 1988; 29: 781–03

    Article  PubMed  CAS  Google Scholar 

  23. Faust G. The tolerability of nilvadipine compared to nifedipine in patients with essential hypertension. J Cardiovasc Pharmacol 1992; 20 Suppl. 6: S56–61

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nilvadipine: an alternative dihydropyridine for treating hypertension. Drugs Ther. Perspect 5, 1–4 (1995). https://doi.org/10.2165/00042310-199505090-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199505090-00001

Keywords

Search

Navigation